Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Clinical Efficacy of Venetoclax in Combination With Azacitidine in Patients With Therapy Related Myelodysplastic Syndrome (t-MDS)

NCT05379166 is registered in ClinicalTrials.gov with Uma Borate as lead sponsor.

NCT NCT05379166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05379166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Clinical Efficacy of Venetoclax in Combination With Azacitidine in Patients With Therapy Related Myelodysplastic Syndrome (t-MDS)
Lead sponsor
Uma Borate
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 23, 2022
Completion date
December 15, 2026
Enrollment
33 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

secondary myelodysplastic syndrome, therapy-related myelodysplastic syndrome